Back to Grants
FEDERAL
Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)
This grant funds the development of biomarkers or composite biomarkers for neurological and neuromuscular disorders.
About this program
The grant aims to support research focused on the identification and validation of biomarkers that can aid in the diagnosis and treatment of neurological and neuromuscular disorders. It is intended for researchers and institutions engaged in clinical trials or related studies. The funding will facilitate innovative approaches to biomarker development, enhancing the understanding and management of these complex conditions.
Eligibility
Eligible applicants include academic institutions, nonprofit organizations, and other research entities involved in biomedical research.